UA118087C2 - Композиція кортикостероїду, застосована перорально - Google Patents
Композиція кортикостероїду, застосована пероральноInfo
- Publication number
- UA118087C2 UA118087C2 UAA201413781A UAA201413781A UA118087C2 UA 118087 C2 UA118087 C2 UA 118087C2 UA A201413781 A UAA201413781 A UA A201413781A UA A201413781 A UAA201413781 A UA A201413781A UA 118087 C2 UA118087 C2 UA 118087C2
- Authority
- UA
- Ukraine
- Prior art keywords
- corticosteroid
- oralized
- alcohol
- corticosteroid composition
- flutzolidon
- Prior art date
Links
- 239000003246 corticosteroid Substances 0.000 title abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 abstract 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 abstract 1
- 229940092705 beclomethasone Drugs 0.000 abstract 1
- 229960004436 budesonide Drugs 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229960002714 fluticasone Drugs 0.000 abstract 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 abstract 1
- -1 flutzolidon Chemical compound 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 210000002438 upper gastrointestinal tract Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Dispersion Chemistry (AREA)
- Virology (AREA)
- Otolaryngology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24764209P | 2009-10-01 | 2009-10-01 | |
| UAA201203919A UA108360C2 (uk) | 2009-10-01 | 2010-09-30 | Тверда фармацевтична композиція кортикостероїду, що розпадається у ротовій порожнині |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA118087C2 true UA118087C2 (uk) | 2018-11-26 |
Family
ID=43823361
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201413781A UA118087C2 (uk) | 2009-10-01 | 2010-09-30 | Композиція кортикостероїду, застосована перорально |
| UAA201203919A UA108360C2 (uk) | 2009-10-01 | 2010-09-30 | Тверда фармацевтична композиція кортикостероїду, що розпадається у ротовій порожнині |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201203919A UA108360C2 (uk) | 2009-10-01 | 2010-09-30 | Тверда фармацевтична композиція кортикостероїду, що розпадається у ротовій порожнині |
Country Status (37)
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US20100216754A1 (en) * | 2007-11-13 | 2010-08-26 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| HUE038452T2 (hu) | 2007-11-13 | 2018-10-29 | Meritage Pharma Inc | Gyomor és bélrendszeri gyulladások kezelésére szolgáló kompozíciók |
| US9050368B2 (en) | 2007-11-13 | 2015-06-09 | Meritage Pharma, Inc. | Corticosteroid compositions |
| WO2010144865A2 (en) * | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| EP2482822B1 (en) * | 2009-10-01 | 2018-08-01 | Adare Pharmaceuticals, Inc. | Orally administered corticosteroid compositions |
| ES2894936T3 (es) * | 2010-06-24 | 2022-02-16 | Viropharma Biologics Llc | Métodos de tratamiento para la inflamación del esófago |
| WO2012020279A1 (en) * | 2010-08-13 | 2012-02-16 | Compagnie Gervais Danone | Product for the upper gastric sphere |
| US8765725B2 (en) | 2012-05-08 | 2014-07-01 | Aciex Therapeutics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
| CN107880091B (zh) | 2012-05-08 | 2020-12-18 | 尼科斯眼药公司 | 疏水性治疗剂的制剂、其制备方法及应用 |
| US9815865B2 (en) | 2013-01-07 | 2017-11-14 | Nicox Ophthalmics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
| US9339489B2 (en) | 2013-03-15 | 2016-05-17 | Aprecia Pharmaceuticals Company | Rapid disperse dosage form containing levetiracetam |
| AU2014228990B2 (en) | 2013-03-15 | 2017-02-02 | Aprecia Pharmaceuticals LLC | Rapid disperse dosage form containing levetiracetam |
| US10716802B2 (en) | 2013-03-15 | 2020-07-21 | The Brigham And Women's Hospital, Inc. | Compounds to modulate intestinal absorption of nutrients |
| GB201308933D0 (en) * | 2013-05-17 | 2013-07-03 | Diurnal Ltd | Paediatric composition |
| US9078853B2 (en) | 2013-06-18 | 2015-07-14 | Cmpd Licensing, Llc | Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders |
| WO2015034678A2 (en) | 2013-09-06 | 2015-03-12 | Aptalis Pharmatech, Inc. | Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis |
| WO2015152517A1 (ko) * | 2014-03-31 | 2015-10-08 | (주)세하바이오 | 항산화 물질 활성 보호를 위한 프롤라민 기반 경구용 필름 제조방법 |
| EP3047846A1 (en) | 2015-01-22 | 2016-07-27 | Ems S.A. | Dosage forms containing fluticasone propionate for the treatment of inflammatory conditions of the esophagus |
| US9980975B2 (en) | 2015-01-22 | 2018-05-29 | Ems S.A. | Dosage forms containing fluticasone propionate for the treatment of inflammatory conditions of the esophagus |
| US20170042806A1 (en) | 2015-04-29 | 2017-02-16 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
| US9867834B2 (en) | 2015-06-15 | 2018-01-16 | Banner Life Sciences Llc | Non-systemic topical compositions comprising corticosteroids |
| US9877971B2 (en) | 2015-06-15 | 2018-01-30 | Banner Life Sciences Llc | Soft lozenges comprising corticosteroids |
| WO2017053970A1 (en) * | 2015-09-24 | 2017-03-30 | The Brigham And Women's Hospital, Inc. | Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients |
| CN105412123B (zh) * | 2015-11-06 | 2018-03-13 | 山东省千佛山医院 | 布地奈德联合三唑类抗真菌药物的应用及其产品 |
| EP3441065B1 (en) | 2016-04-06 | 2024-10-09 | Astellas Pharma Inc. | Fast-eluting three-dimensional molding, filament for fast-eluting three-dimensional molding, and material for fast-eluting three-dimensional molding |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| TWI777515B (zh) | 2016-08-18 | 2022-09-11 | 美商愛戴爾製藥股份有限公司 | 治療嗜伊紅性食道炎之方法 |
| US11986448B2 (en) | 2016-11-17 | 2024-05-21 | Cmpd Licensing, Llc | Compounded compositions and methods for treating pain |
| US10525025B2 (en) | 2016-11-17 | 2020-01-07 | Cmpd Licensing, Llc | Compounded compositions and methods for treating pain |
| US11737975B2 (en) | 2016-11-17 | 2023-08-29 | Cmpd Licensing, Llc | Compounded compositions and methods for treating pain |
| US9999604B2 (en) | 2016-11-17 | 2018-06-19 | Cmpd Licensing, Llc | Compounded solutions of diclofenac and lidocaine and methods |
| US10966946B2 (en) | 2016-11-17 | 2021-04-06 | Cmpd Licensing, Llc | Compounded compositions and methods for treating pain |
| CN107595765A (zh) * | 2017-09-22 | 2018-01-19 | 沈阳兴齐眼药股份有限公司 | 一种眼用缓释药物递送系统及其制备方法 |
| WO2019157453A1 (en) * | 2018-02-12 | 2019-08-15 | Trilogy Therapeutics, Inc. | Caspofungin compositions for inhalation |
| SI25373A (sl) | 2018-05-08 | 2018-08-31 | Danijela Marković | Naravna orodisperzibilna tableta |
| ES3043383T3 (en) | 2018-10-24 | 2025-11-25 | Ferring Bv | Mucoadhesive pharmaceutical compositions of corticosteroids |
| WO2020227437A1 (en) * | 2019-05-06 | 2020-11-12 | Axial Biotherapeutics, Inc. | Sustained release solid dosage forms for modulating the colonic microbiome |
| KR20220074915A (ko) * | 2019-10-01 | 2022-06-03 | 엘로디 파마슈티컬스, 엘.피. | 호산구성 식도염을 치료하고 칸디다증을 감소시키는 방법 |
| KR102275997B1 (ko) * | 2019-11-07 | 2021-07-13 | 연세대학교 산학협력단 | 숙주지향치료를 위한 조성물 |
| JP7720226B2 (ja) * | 2020-11-09 | 2025-08-07 | 東和薬品株式会社 | リバーロキサバン含有口腔内崩壊錠 |
| CN114146089B (zh) * | 2021-12-15 | 2023-06-16 | 安徽贝克生物制药有限公司 | 含依非韦伦、替诺福韦和恩曲他滨的药物组合物 |
| CN119997959A (zh) * | 2022-07-28 | 2025-05-13 | 威斯康星州医药大学股份有限公司 | 用于治疗反流的缓释口服福沙那韦制剂 |
| US11904046B1 (en) * | 2022-11-14 | 2024-02-20 | Eton Pharmaceuticals, Inc. | Hydrocortisone oral liquid formulations |
| CN116869927B (zh) * | 2023-09-06 | 2023-11-10 | 中国医学科学院北京协和医院 | 一种用于治疗嗜酸性食管炎的食道温敏凝胶 |
Family Cites Families (118)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1170188A (en) | 1967-09-15 | 1969-11-12 | Bayer Ag | N-trityl-imidazoles and salts and uses thereof |
| SE378109B (enExample) | 1972-05-19 | 1975-08-18 | Bofors Ab | |
| DE2260384C3 (de) * | 1972-12-09 | 1979-11-29 | Hoechst Ag, 6000 Frankfurt | Oral zu applizierendes Corticosteroid-Präparat |
| US4080448A (en) | 1974-11-13 | 1978-03-21 | Mirsky Louis H | Method of treating cellular stress |
| BE887518A (fr) | 1980-02-15 | 1981-08-13 | Glaxo Group Ltd | Cartothioates d'androstanes |
| SE8004580L (sv) | 1980-06-19 | 1981-12-20 | Draco Ab | Farmaceutisk beredning |
| CY1359A (en) | 1981-02-02 | 1987-08-07 | Schering Corp | Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them |
| GB8630913D0 (en) | 1986-12-24 | 1987-02-04 | Glaxo Group Ltd | Pharmaceutical compositions |
| US5446070A (en) | 1991-02-27 | 1995-08-29 | Nover Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
| ZA892859B (en) | 1988-04-22 | 1989-12-27 | Advanced Polymer Systems Inc | Porous particles in preparations involving immiscible phases |
| US5278175A (en) | 1990-02-02 | 1994-01-11 | Pfizer Inc. | Triazole antifungal agents |
| GB9002375D0 (en) | 1990-02-02 | 1990-04-04 | Pfizer Ltd | Triazole antifungal agents |
| GR1001529B (el) | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
| CA2101773A1 (en) | 1991-01-31 | 1992-08-01 | Toyoichi Tanaka | Interpenetrating-polymer network phase-transition gels |
| US5252337A (en) | 1991-06-25 | 1993-10-12 | Eurand America, Inc. | Controlled release calcium channel blocker microcapsules |
| PT735884E (pt) | 1993-12-20 | 2000-09-29 | Minnesota Mining & Mfg | Formulacoes de aerossol de flunisolida |
| US5639475A (en) | 1995-02-03 | 1997-06-17 | Eurand America, Incorporated | Effervescent microcapsules |
| SE9501384D0 (sv) * | 1995-04-13 | 1995-04-13 | Astra Ab | Process for the preparation of respirable particles |
| GB9517062D0 (en) | 1995-08-18 | 1995-10-25 | Scherer Ltd R P | Pharmaceutical compositions |
| US5863910A (en) | 1996-01-12 | 1999-01-26 | Bolonick; Joel | Treatment of chronic inflammatory disorders of the gastrointestinal tract |
| DE19606151C2 (de) | 1996-02-20 | 1999-05-12 | Losan Pharma Gmbh | Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben |
| US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
| CA2258159C (en) | 1996-06-14 | 2006-03-21 | Kyowa Hakko Kogyo Co., Ltd. | Intraorally rapidly disintegrable tablet |
| HUP0000116A3 (en) | 1996-10-01 | 2000-08-28 | Stanford Res Inst Int | Taste-masked microcapsule compositions and methods of manufacture |
| SE9604486D0 (sv) | 1996-12-05 | 1996-12-05 | Astra Ab | Novel formulation |
| GB9707934D0 (en) | 1997-04-18 | 1997-06-04 | Danbiosyst Uk | Improved delivery of drugs to mucosal surfaces |
| IT1291362B1 (it) | 1997-05-13 | 1999-01-07 | Vectorpharma Int | Composizioni farmaceutiche multicomponente bifasiche contenenti sostanze atte a modificare la partizione dei principi attivi |
| RO118174B1 (ro) | 1997-08-21 | 2003-03-28 | Aventis Pharma Deutschland Gmbh | Lac de unghii şi utilizarea acestuia |
| GB9722426D0 (en) | 1997-10-23 | 1997-12-24 | Univ London Pharmacy | Controlled release formulations |
| DE69901938T3 (de) | 1998-03-06 | 2012-08-02 | Aptalis Pharma S.R.L. | Schnell zerfallende tablette |
| SE514128C2 (sv) | 1998-03-17 | 2001-01-08 | Pharmalink Ab | Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit |
| FR2781156B1 (fr) | 1998-07-20 | 2001-06-29 | Lafon Labor | Composition pharmaceutique destinee notamment a la prevention et au traitement des radiomucites et des chimiomucites |
| US6596298B2 (en) | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
| US6863378B2 (en) | 1998-10-16 | 2005-03-08 | Silverbrook Research Pty Ltd | Inkjet printer having enclosed actuators |
| GB9901819D0 (en) | 1999-01-27 | 1999-03-17 | Scherer Corp R P | Pharmaceutical compositions |
| ES2388425T5 (es) | 1999-04-23 | 2020-02-12 | Leo Pharma As | Composición farmacéutica no acuosa para uso dérmico para tratar la psoriasis que comprende una vitamina D, un corticoesteroide y un componente disolvente |
| GB9915319D0 (en) | 1999-06-30 | 1999-09-01 | Unilever Plc | Hair treatment compositions |
| CA2317999C (en) | 1999-09-11 | 2004-11-09 | Glaxo Group Limited | Pharmaceutical formulation of fluticasone propionate |
| WO2001039749A2 (en) | 1999-11-30 | 2001-06-07 | Panacea Biotec Limited | Fast dissolving composition with prolonged sweet taste |
| AU2001279284A1 (en) | 2000-07-05 | 2002-01-14 | Capricorn Pharma, Inc | Rapid-melt semi-solid compositions, methods of making same and methods of using same |
| KR100446101B1 (ko) * | 2000-12-07 | 2004-08-30 | 주식회사 삼양사 | 수난용성 약물의 서방성 제형 조성물 |
| EP1367999A4 (en) | 2001-02-16 | 2007-04-18 | Lavipharm Lab Inc | WATER-SOLUBLE COMPLEXES WITH PLEASANT TASTE |
| US20030050312A1 (en) | 2001-03-12 | 2003-03-13 | Hjorth Thyge Borup | Novel tablets and capsules and a process for its preparation |
| EP1418945A2 (en) * | 2001-03-13 | 2004-05-19 | Angiotech Pharmaceuticals, Inc. | Micellar drug delivery vehicles and uses thereof |
| ATE333269T1 (de) | 2001-05-10 | 2006-08-15 | Astellas Pharma Inc | In der mundhöhle schnell zerfallende tabletten und prozess zu deren herstellung |
| US6872405B2 (en) * | 2001-05-10 | 2005-03-29 | Yamanouchi Pharmaceutical Co., Ltd. | Quick-disintegrating tablet in buccal cavity and manufacturing method thereof |
| US6656493B2 (en) | 2001-07-30 | 2003-12-02 | Wm. Wrigley Jr. Company | Edible film formulations containing maltodextrin |
| FR2831820B1 (fr) | 2001-11-05 | 2004-08-20 | Ethypharm Sa | Comprime orodispersible presentant une grande homogeneite et son procede de preparation |
| US20030206978A1 (en) | 2001-11-29 | 2003-11-06 | Bob Sherwood | Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose |
| US20040009212A1 (en) | 2002-01-30 | 2004-01-15 | Pharma Power Biotec Co. Ltd. | Mucoadhesive thermoresponsive medicament-carrier composition |
| JP4173670B2 (ja) * | 2002-03-08 | 2008-10-29 | 旭化成ファーマ株式会社 | 口腔内崩壊製剤 |
| AU2003230823A1 (en) | 2002-04-05 | 2003-10-27 | United States Of America As Represented By The Administrator Of The National Aeronautics And Space | Polyimides from 2,3,3',4'-biphenyltetracarboxylic dianhydride and aromatic diamines |
| PL220850B1 (pl) * | 2002-05-03 | 2016-01-29 | Janssen Pharmaceutica Nv | Kopolimer dwublokowy, kompozycja zawierająca składnik aktywny i jej zastosowanie oraz sposób jej wytwarzania |
| AU2003253870A1 (en) | 2002-07-10 | 2004-01-23 | I/O Controls Corporation | Fiber optic control network and related method |
| WO2004021997A2 (en) * | 2002-09-06 | 2004-03-18 | Microbia, Inc. | Inhibitors of fungal invasion |
| WO2004023984A2 (en) | 2002-09-13 | 2004-03-25 | Smith C Steven | Novel composition and method for treatment of upper respiratory conditions |
| US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
| EP1595533B1 (en) * | 2003-01-21 | 2010-01-06 | Nippon Shinyaku Co., Ltd. | Tablet quickly melting in oral cavity |
| CA2512559A1 (en) * | 2003-01-31 | 2004-08-12 | Orexo Ab | A rapid-acting pharmaceutical composition |
| US20040208833A1 (en) | 2003-02-04 | 2004-10-21 | Elan Pharma International Ltd. | Novel fluticasone formulations |
| US8012505B2 (en) | 2003-02-28 | 2011-09-06 | Alk-Abello A/S | Dosage form having a saccharide matrix |
| US20040265375A1 (en) | 2003-04-16 | 2004-12-30 | Platteeuw Johannes J. | Orally disintegrating tablets |
| US20050009848A1 (en) * | 2003-07-10 | 2005-01-13 | Icn Pharmaceuticals Switzerland Ltd. | Use of antivirals against inflammatory bowel diseases |
| US20060134054A1 (en) | 2003-12-19 | 2006-06-22 | Council Of Scientific And Industrial Research | Polymer composition for pH dependent dissolution behavior and process for preparation thereof |
| CA2558393A1 (en) | 2004-03-10 | 2005-09-22 | Schering Aktiengesellschaft | Compositions comprising drospirenone molecularly dispersed |
| US8545881B2 (en) | 2004-04-19 | 2013-10-01 | Eurand Pharmaceuticals, Ltd. | Orally disintegrating tablets and methods of manufacture |
| EP1634586B1 (en) | 2004-09-09 | 2007-02-14 | Laboratorio Medinfar-Produtos Farmaceuticos, S.A. | Fast water-dispersible domperidone tablets |
| US20060105038A1 (en) | 2004-11-12 | 2006-05-18 | Eurand Pharmaceuticals Limited | Taste-masked pharmaceutical compositions prepared by coacervation |
| US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
| US20060292099A1 (en) | 2005-05-25 | 2006-12-28 | Michael Milburn | Treatment of eye disorders with sirtuin modulators |
| WO2007028247A1 (en) * | 2005-09-09 | 2007-03-15 | University Of Manitoba | Fast-disintegrating epinephrine tablets for buccal or sublingual administration |
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8324192B2 (en) | 2005-11-12 | 2012-12-04 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| US8679545B2 (en) | 2005-11-12 | 2014-03-25 | The Regents Of The University Of California | Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract |
| JP2007158225A (ja) | 2005-12-08 | 2007-06-21 | Canon Inc | 露光装置 |
| CN1985799B (zh) * | 2005-12-19 | 2011-11-09 | 量子高科（北京）研究院有限公司 | 口腔崩解制剂的制备方法 |
| EP1978939A2 (en) * | 2005-12-27 | 2008-10-15 | Jubilant Organosys Limited | Mouth dissolving pharmaceutical composition and process for preparing the same using a high amount of silicon dioxine |
| US20080260655A1 (en) * | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| EP1958613A1 (en) | 2007-02-15 | 2008-08-20 | Polichem S.A. | Dermal film-forming liquid formulations for drug release to skin |
| EP2148659A2 (en) | 2007-04-13 | 2010-02-03 | Somaxon Pharmaceuticals, Inc. | Low-dose doxepin formulations |
| US20090123551A1 (en) * | 2007-11-13 | 2009-05-14 | Meritage Pharma, Inc. | Gastrointestinal delivery systems |
| US20150231156A1 (en) | 2007-11-13 | 2015-08-20 | Meritage Pharma, Inc. | Corticosteroid compositions |
| US9050368B2 (en) * | 2007-11-13 | 2015-06-09 | Meritage Pharma, Inc. | Corticosteroid compositions |
| HUE038452T2 (hu) * | 2007-11-13 | 2018-10-29 | Meritage Pharma Inc | Gyomor és bélrendszeri gyulladások kezelésére szolgáló kompozíciók |
| US20100216754A1 (en) | 2007-11-13 | 2010-08-26 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
| KR20100119539A (ko) * | 2007-12-10 | 2010-11-09 | 유란드, 인코포레이티드 | 다이펜하이드라민을 포함하는 경구 분해성 정제 |
| CN105496978A (zh) | 2007-12-21 | 2016-04-20 | 阿代尔制药股份有限公司 | 替马西泮的口腔崩解片组合物 |
| JP2009173552A (ja) * | 2008-01-21 | 2009-08-06 | Lion Corp | 胃腸薬 |
| SE533435C2 (sv) | 2008-04-03 | 2010-09-28 | Hm Power Ab | Vridmomentsöverförande arrangemang vid ett vindkraftverk |
| US20090264392A1 (en) | 2008-04-21 | 2009-10-22 | Meritage Pharma, Inc. | Treating eosinophilic esophagitis |
| ME01256B (me) | 2008-07-21 | 2013-06-20 | Dr Falk Pharma Gmbh | Farmaceutska formulacija za lečenje gornjeg digestivnog trakta |
| MX2011001487A (es) | 2008-08-08 | 2011-03-30 | Mcneil Ppc Inc | Uso de sucralosa como agente granulante. |
| DK2328553T3 (da) | 2008-08-20 | 2020-08-24 | Univ California | Corticosteroider til behandling af inflammatoriske sygdomme i mave-tarm-kanalen |
| EP2381835A1 (en) | 2009-01-15 | 2011-11-02 | Nestec S.A. | Methods of diagnosing and treating dysphagia |
| EP2398470A4 (en) | 2009-02-23 | 2013-03-06 | Aptalis Pharmatech Inc | CONTROLLED RELEASE COMPOSITIONS COMPRISING A PROTON PUMP INHIBITOR |
| WO2010144865A2 (en) * | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| BR112012005117A2 (pt) | 2009-09-07 | 2016-05-03 | Dbv Tech | método de tratamento de esofagite eosinofílica |
| EP2482822B1 (en) | 2009-10-01 | 2018-08-01 | Adare Pharmaceuticals, Inc. | Orally administered corticosteroid compositions |
| NZ600123A (en) | 2009-11-30 | 2015-04-24 | Aptalis Pharmatech Inc | Compressible-coated pharmaceutical compositions and tablets and methods of manufacture |
| ES2894936T3 (es) | 2010-06-24 | 2022-02-16 | Viropharma Biologics Llc | Métodos de tratamiento para la inflamación del esófago |
| MX365568B (es) | 2010-12-02 | 2019-06-07 | Adare Pharmaceuticals Inc | Granulos de dispersion rapida, comprimidos de disolucion oral y metodos. |
| AU2012208912B2 (en) | 2011-01-18 | 2016-03-03 | Holland Bloorview Kids Rehabilitation Hospital | Method and device for swallowing impairment detection |
| CA2824392C (en) | 2011-01-28 | 2020-05-12 | Nestec S.A. | Apparatuses and methods for diagnosing swallowing dysfunction |
| JP2015522653A (ja) | 2012-07-26 | 2015-08-06 | ルピン・リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ | プロトンポンプ阻害剤の医薬組成物 |
| TWI634900B (zh) | 2013-07-11 | 2018-09-11 | 再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法 |
| WO2015034678A2 (en) | 2013-09-06 | 2015-03-12 | Aptalis Pharmatech, Inc. | Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis |
| DK2886108T4 (da) | 2013-12-23 | 2023-01-30 | Dr Falk Pharma Gmbh | Optimeret farmaceutisk formulering til behandling af inflammatoriske ændringer af øsofagus |
| US10294517B2 (en) | 2014-03-17 | 2019-05-21 | Children's Hospital Medical Center | Genetic test for determining susceptibility for eosinophilic esophagitis |
| US10176301B2 (en) | 2014-09-11 | 2019-01-08 | Meritage Pharma, Inc. | Systems, methods, and software for providing a patient-reported outcome measure of dysphagia patients with eosinophilic esophagitis |
| US9980975B2 (en) | 2015-01-22 | 2018-05-29 | Ems S.A. | Dosage forms containing fluticasone propionate for the treatment of inflammatory conditions of the esophagus |
| US10869592B2 (en) | 2015-02-23 | 2020-12-22 | Uroviu Corp. | Handheld surgical endoscope |
| KR20240052871A (ko) | 2016-04-27 | 2024-04-23 | 애브비 인코포레이티드 | 항-il-13 항체를 이용한 il-13 활성이 유해한 질환의 치료 방법 |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| TWI777515B (zh) | 2016-08-18 | 2022-09-11 | 美商愛戴爾製藥股份有限公司 | 治療嗜伊紅性食道炎之方法 |
| US20200381097A1 (en) | 2018-02-21 | 2020-12-03 | Adare Pharmaceuticals Us, L.P. | Methods of treating eosinophilic esophagitis |
| KR20220074915A (ko) | 2019-10-01 | 2022-06-03 | 엘로디 파마슈티컬스, 엘.피. | 호산구성 식도염을 치료하고 칸디다증을 감소시키는 방법 |
| WO2022020464A1 (en) | 2020-07-21 | 2022-01-27 | Ellodi Pharmaceuticals, L.P. | Modified release rapidly disintegrating compositions of proton pump inhibitors |
| JP2024515299A (ja) | 2021-04-20 | 2024-04-08 | エロディ ファーマシューティカルズ，エル．ピー． | 食道狭窄の治療方法 |
-
2010
- 2010-09-30 EP EP10821232.5A patent/EP2482822B1/en not_active Revoked
- 2010-09-30 EP EP20192973.4A patent/EP3760187A1/en active Pending
- 2010-09-30 CN CN201710261488.7A patent/CN107252488A/zh active Pending
- 2010-09-30 KR KR1020147017747A patent/KR20140088236A/ko not_active Ceased
- 2010-09-30 EA EA201290171A patent/EA024084B1/ru unknown
- 2010-09-30 NZ NZ624922A patent/NZ624922A/en active IP Right Revival
- 2010-09-30 ES ES18178891T patent/ES2742525T3/es active Active
- 2010-09-30 HU HUE18178891A patent/HUE046748T2/hu unknown
- 2010-09-30 DK DK18178891.0T patent/DK3403654T3/da active
- 2010-09-30 UA UAA201413781A patent/UA118087C2/uk unknown
- 2010-09-30 DK DK10821232.5T patent/DK2482822T3/en active
- 2010-09-30 AU AU2010300550A patent/AU2010300550B2/en not_active Ceased
- 2010-09-30 CA CA3037273A patent/CA3037273C/en active Active
- 2010-09-30 RS RS20180962A patent/RS57595B1/sr unknown
- 2010-09-30 PL PL18178891T patent/PL3403654T3/pl unknown
- 2010-09-30 MX MX2017002757A patent/MX380787B/es unknown
- 2010-09-30 WO PCT/US2010/050860 patent/WO2011041509A1/en not_active Ceased
- 2010-09-30 EP EP14184844.0A patent/EP2845595A1/en active Pending
- 2010-09-30 BR BR112012007110-6A patent/BR112012007110A2/pt not_active IP Right Cessation
- 2010-09-30 SG SG10201405886WA patent/SG10201405886WA/en unknown
- 2010-09-30 PL PL10821232T patent/PL2482822T3/pl unknown
- 2010-09-30 LT LTEP18178891.0T patent/LT3403654T/lt unknown
- 2010-09-30 KR KR1020157008676A patent/KR20150043548A/ko not_active Ceased
- 2010-09-30 BR BR122022005637-7A patent/BR122022005637B1/pt active IP Right Grant
- 2010-09-30 MY MYPI2012001434A patent/MY171317A/en unknown
- 2010-09-30 JP JP2012532304A patent/JP2013506683A/ja active Pending
- 2010-09-30 CA CA2940931A patent/CA2940931C/en active Active
- 2010-09-30 CN CN201611030531.0A patent/CN106421797A/zh active Pending
- 2010-09-30 PT PT18178891T patent/PT3403654T/pt unknown
- 2010-09-30 SI SI201031925T patent/SI3403654T1/sl unknown
- 2010-09-30 CN CN2010800470168A patent/CN102665722A/zh active Pending
- 2010-09-30 EA EA201491358A patent/EA031157B9/ru unknown
- 2010-09-30 CA CA2776164A patent/CA2776164C/en active Active
- 2010-09-30 SM SM20190468T patent/SMT201900468T1/it unknown
- 2010-09-30 MX MX2019005289A patent/MX390734B/es unknown
- 2010-09-30 EP EP18178891.0A patent/EP3403654B1/en active Active
- 2010-09-30 PT PT10821232T patent/PT2482822T/pt unknown
- 2010-09-30 DE DE202010018594.7U patent/DE202010018594U1/de not_active Expired - Lifetime
- 2010-09-30 ME MEP-2019-223A patent/ME03471B/me unknown
- 2010-09-30 GE GEAP201012674A patent/GEP20156281B/en unknown
- 2010-09-30 KR KR1020127010779A patent/KR20120104975A/ko not_active Ceased
- 2010-09-30 HU HUE10821232A patent/HUE040119T2/hu unknown
- 2010-09-30 LT LTEP10821232.5T patent/LT2482822T/lt unknown
- 2010-09-30 UA UAA201203919A patent/UA108360C2/ru unknown
- 2010-09-30 HR HRP20181266TT patent/HRP20181266T1/hr unknown
- 2010-09-30 SI SI201031731T patent/SI2482822T1/sl unknown
- 2010-09-30 SG SG10201704847WA patent/SG10201704847WA/en unknown
- 2010-09-30 ES ES10821232.5T patent/ES2683864T3/es active Active
- 2010-09-30 SG SG10201912526TA patent/SG10201912526TA/en unknown
- 2010-09-30 MX MX2012003823A patent/MX364947B/es active IP Right Grant
- 2010-09-30 NZ NZ599401A patent/NZ599401A/en active IP Right Revival
- 2010-09-30 RS RSP20191082 patent/RS59241B1/sr unknown
- 2010-10-01 SM SM20180427T patent/SMT201800427T1/it unknown
- 2010-10-01 TW TW099133628A patent/TWI562779B/zh active
- 2010-10-01 TW TW104107443A patent/TWI594754B/zh active
- 2010-10-01 PY PY201001041126A patent/PY1041126A/es unknown
- 2010-10-01 UY UY0001032925A patent/UY32925A/es not_active Application Discontinuation
- 2010-10-01 US US12/896,005 patent/US8771729B2/en active Active
- 2010-10-01 AR ARP100103589A patent/AR078499A1/es unknown
-
2012
- 2012-03-27 ZA ZA2012/02208A patent/ZA201202208B/en unknown
- 2012-03-29 IL IL218928A patent/IL218928A/en active IP Right Grant
- 2012-03-29 MX MX2020007226A patent/MX2020007226A/es unknown
- 2012-03-29 MX MX2022003132A patent/MX2022003132A/es unknown
- 2012-03-30 CL CL2012000794A patent/CL2012000794A1/es unknown
- 2012-04-04 CO CO12056405A patent/CO6531427A2/es not_active Application Discontinuation
-
2013
- 2013-02-22 ZA ZA2013/01380A patent/ZA201301380B/en unknown
-
2014
- 2014-06-03 US US14/294,660 patent/US9486407B2/en active Active
- 2014-06-23 US US14/311,732 patent/US9387167B2/en active Active
- 2014-12-24 JP JP2014261068A patent/JP6249935B2/ja active Active
-
2015
- 2015-05-20 IL IL238915A patent/IL238915A/en active IP Right Grant
-
2016
- 2016-07-08 US US15/205,390 patent/US9849084B2/en active Active
- 2016-10-07 JP JP2016199156A patent/JP6293230B2/ja active Active
-
2017
- 2017-11-17 US US15/816,154 patent/US10632069B2/en active Active
-
2018
- 2018-02-13 JP JP2018022869A patent/JP2018100286A/ja active Pending
-
2019
- 2019-08-08 HR HRP20191435 patent/HRP20191435T1/hr unknown
- 2019-08-19 CY CY20191100883T patent/CY1122713T1/el unknown
-
2020
- 2020-02-24 JP JP2020028900A patent/JP7042015B2/ja active Active
- 2020-03-17 US US16/821,464 patent/US11246828B2/en active Active
-
2021
- 2021-04-21 US US17/236,295 patent/US11266598B2/en active Active
-
2022
- 2022-01-05 US US17/569,047 patent/US12290598B2/en active Active
- 2022-03-12 JP JP2022038712A patent/JP2022078275A/ja active Pending
-
2023
- 2023-08-31 JP JP2023140872A patent/JP2023166486A/ja active Pending
-
2025
- 2025-04-04 US US19/170,231 patent/US20260021041A1/en active Pending
- 2025-11-28 US US19/403,672 patent/US20260083668A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2021019I1 (no) | Kombinasjon av formoterol (inkludert farmasøytisk akseptable salter, estere, solvater eller enantiomerer derav), glykopyrrolat (inkludert farmasøytisk akseptable salter, estere, solvater eller enantiomerer derav) og budesonid (inkludert farmasøytisk akseptable salter, estere, solvater eller enantiomerer derav) | |
| EA031157B9 (ru) | Вводимая перорально кортикостероидная композиция | |
| EP2643045A4 (en) | THERAPEUTIC PROCESSES AND COMPOSITIONS FOR SOLID FORM DELIVERY | |
| EP2575821A4 (en) | GALLENIC ACID FLUID FOR THE TREATMENT OF DIABETES, ADIPOSITAS AND INFLAMMABLE STOMACH DISEASES | |
| MX387667B (es) | Composiciones corticosteroides. | |
| EP2535339A4 (en) | POLYMORPHES OF DASATINIB, METHOD OF MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
| LT2596786T (lt) | Eikozapentaeno rūgšties etilo esterio naudojimas hipertriglicidemijai gydyti | |
| HUE040307T2 (hu) | Új oxintomodulin-származékok és azokat tartalmazó gyógyszerészeti készítmények elhízás kezelésére | |
| EP2419138A4 (en) | GEL COMPOSITIONS FOR THE ADMINISTRATION OF PHARMACEUTICALLY ACTIVE COMPOUNDS | |
| EP2552417A4 (en) | PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF BLADDER HYPERACTIVITY | |
| EP2760433A4 (en) | PH-DEPENDENT SUPPORTS FOR THE TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINALTRAKTS, COMPOSITIONS, AND THEIR PREPARATION AND USE | |
| IL222092B (en) | Compositions and methods for improved retention of a pharmaceutical composition at a local administration site | |
| DK2306988T3 (da) | Farmaceutisk formulering til behandling af den øvre fordøjelseskanal | |
| WO2008012338A3 (en) | Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions | |
| FR2981572B1 (fr) | Compositions pharmaceutiques d'acide ursodesoxycholique | |
| TR201000733A2 (tr) | Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler. | |
| EE201300004A (et) | Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks | |
| WO2011123524A3 (en) | Macrolide inhibitors of mtor | |
| CL2011000093A1 (es) | Compuestos derivados de un ester piperidinilico del acido bifenil-2-ilcarbamico; composicion farmaceutica; combinacion farmaceutica; y su uso para broncoconstriccion, enfermedades obstructivas o inflamatorias de las vias respiratorias. | |
| HUE051538T2 (hu) | Kortikoszteroidok a gyomor-bél traktus gyulladásos betegségeinek kezelésére | |
| EP2651395A4 (en) | PHARMACEUTICAL COMPOSITIONS OF SELECTIVE FACTOR XA INHIBITORS FOR ORAL ADMINISTRATION | |
| IL218001A0 (en) | Pharmaceutical composition for the treatment of mcp-1 mediated inflammatory diseases | |
| EP2384745A3 (en) | Modified release pharmaceutical compositions of dexlansoprazole | |
| FR2940116B1 (fr) | Formulation pour l'administration d'hypolipemiant par voie trans-muqueuse buccale | |
| FR2947729B1 (fr) | Composition pharmaceutique pour le traitement du diabete de type ii par voie trans-muqueuse buccale |